EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

p1/s1, a 3’-nucleotidase/nuclease, allows Leishmania major to circumvent host innate immune response mechanisms

Stella M Schmelzle, Michaela Bergmann, Bianca Walber, Jamal Shamsara, Tanja Ziesmann, Ute Distler, Csaba Miskey, Liam Childs, Peter Kolb, Stefan Tenzer, Katrin Bagola, Ger van Zandbergen iD

PLOS Pathogens · 20.05.2026 · 22 (5) · e1014197

DOI: 10.1371/journal.ppat.1014197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 20.05.2026. Verfasst von Stella M Schmelzle und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany. Hauptthemen laut MEDLINE: Leishmania major, Immunity, Innate, Nucleotidases, Host-Parasite Interactions. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LOEWE Zentrum DRUID, LOEWE-Zentrum für Translationale Medizin und Pharmakologie, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

3’-nucleotidases/nucleases, distinct class I nucleases of protozoan parasites, play a pivotal role in extracellular purine salvage. As Leishmania are purine auxotrophs and lack de novo synthesis, ectoenzymes facilitating nucleotide and nucleic acid cleavage are indispensable for subsequent uptake. Employing quantitative proteomics, we characterized a class I nuclease p1/s1 cluster in L. major that comprises enzymes exhibiting dual 3’-nucleotidase and endonuclease activity. Expression of these enzymes is induced upon miltefosine or staurosporine treatment and was specifically detected in stationary-phase, but not in logarithmic-phase promastigotes. After confirming secretion of p1/s1, ecto-enzymatic activity was detected on parasites and in the culture supernatant. Viable null mutants deficient for the p1/s1 cluster were only obtained when a diCre-based inducible knockout system was applied, whereas direct deletion approaches were lethal. The viable knockout strains exhibited significantly reduced 3’-nucleotidase/nuclease activity. Notably, these parasites adapted by compensatory enrichment of various alternative purine salvage proteins at the proteomic level. Furthermore, both enzymatic functions implied mechanisms of host-pathogen interactions to facilitate infection establishment: Utilizing 3’-nucleotidase activity, Leishmania generate extracellular adenosine to suppress inflammatory cytokine secretion from macrophages and reduce lymphocyte proliferation in a human primary cell model. The presence of ecto-nucleases also allowed these parasites to degrade and survive neutrophil extracellular traps, a potent first-line innate immune mechanism in pathogen defense. In summary, our integrative approach combining proteomics, immunological and genome editing methods expands current knowledge about Leishmania major 3’-nucleotidases/nucleases. By offering new insights into the diverse involvements in host-pathogen interactions, we highlight p1/s1 as pivotal factor during infection and potential drug target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania majorImmunity, InnateNucleotidasesHost-Parasite InteractionsProtozoan ProteinsImmune EvasionLeishmaniasisHumansAnimals

Substanzen

Nucleotidases3'-nucleotidaseProtozoan Proteins

Autor:innen und Institutionen

  • Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
  • Institute for Pharmaceutical Chemistry, Philipps-Universität Marburg, Marburg, Germany.
  • Core Facility "Chemoinformatics & Molecular AI", Philipps-Universität Marburg, Marburg, Germany.
  • Institute for Immunology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Division Haematology, Cell and Gene Therapy, Genomics Core Facility, Paul-Ehrlich-Institut, Langen, Germany.

ORCID-Profile: Ger van Zandbergen

Förderung

  • LOEWE Zentrum DRUID
  • LOEWE-Zentrum für Translationale Medizin und Pharmakologie
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schmelzle, S. M., Bergmann, M., Walber, B., Shamsara, J., Ziesmann, T., Distler, U., Miskey, C., Childs, L., Kolb, P., Tenzer, S., Bagola, K., & van Zandbergen, G. (2026). p1/s1, a 3’-nucleotidase/nuclease, allows Leishmania major to circumvent host innate immune response mechanisms. PLOS Pathogens, 22(5), e1014197. https://doi.org/10.1371/journal.ppat.1014197

Vancouver

Schmelzle SM, Bergmann M, Walber B, Shamsara J, Ziesmann T, Distler U, et al. p1/s1, a 3’-nucleotidase/nuclease, allows Leishmania major to circumvent host innate immune response mechanisms. PLOS Pathogens. 2026;22(5):e1014197. doi:10.1371/journal.ppat.1014197

BibTeX
@article{Schmelzle2026,
  author = {Schmelzle, Stella M and Bergmann, Michaela and Walber, Bianca and Shamsara, Jamal and Ziesmann, Tanja and Distler, Ute and Miskey, Csaba and Childs, Liam and Kolb, Peter and Tenzer, Stefan and Bagola, Katrin and van Zandbergen, Ger},
  title = {p1/s1, a 3’-nucleotidase/nuclease, allows Leishmania major to circumvent host innate immune response mechanisms},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {e1014197},
  doi = {10.1371/journal.ppat.1014197}
}
Kostenlos starten →